XBiotech annual meeting elects five directors; auditor ratified

XBiotech Inc.

John Simard, Jan-Paul Waldin, W. Thorpe McKenzie, Donald MacAdam, and Peter Libby re-elected as directors.
Auditor Whitley Penn LLP ratified for FY 2023 with 10,983,720 votes for, 51,402 against, 1,615 abstain.
All director nominees received majority support; abstentions and broker non-votes noted.
Meeting held June 23, 2023; all items voted in line with Board recommendations.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

XBiotech Inc. shareholders approved Ratification of the selection of Whitley Penn LLP as the Company’s independent registered public accounting firm for the fiscal year ending 2023 at the 2023-06-23 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-23

Exact text from the filing

Proposal #2 Ratification of the selection of Whitley Penn LLP as the Company’s independent registered public accounting firm for the fiscal year ending 2023 For Against Abstain Broker Non-Votes 10,983,720.00 51,402.00 1,615.00 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

XBiotech Inc. shareholders approved Election of five members of the Board of Directors at the 2023-06-23 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-23

Exact text from the filing

The annual meeting of the stockholders of XBiotech Inc. (the “Company”) was held on June 23, 2023.

View on SEC.gov

Browse all shareholder votes →

XBiotech Inc. filing history →

Source: SEC EDGAR

accession 0001171843-23-004095

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.